New Drug Evaluations: Metronidazole (Flagyl IV®,Searle)

Baines EJ. Metronidazole: its past, present and future. J Antimicrob Chemother 1978; 4 (suppl C): 97–111.

Brogden RN Heel RC Speight TM Avery GS. Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs 1978: 16: 387–417.

Edwards DI. Mechanism of antimicrobial action of metronidazole. J Antimicrob Chemother 1979; 5: 499–502.

Muller M. Mode of action of metronidazole on anaerobic micro-organisms. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 221–8.

Finegold SM. Current status of therapy of anaerobic infections in humans. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 273–8.

Hager WD Brown ST Kraus SJ Metronidazole for vaginal trichomoniasis. JAMA 1980; 244: 1219–20.

Knight R. The chemotherapy of amoebiasis. J Antimicrob Chemother 1980; 6: 577–93.

Metronidazole (Flagyl). Med Lett 1979; 21: 89–90.

Chow AW Patten V Bendnorz D. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother 1978; 13: 416–22.

Pheifer TA Forsyth PS Durfee MA Nonspecific vaginitis. Role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med 1978; 295: 1429–31.

Bartlett JG. Anaerobes in human infections. In: Fine-Gold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 273–8.

Chow AW Patten V Guze LB. Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive bacilli. J Infect Dis 1975; 131: 182–5.

Dornbusch K Nord CE Dahlback A. Antibiotic susceptibility of Clostridium species isolated from human infections. Stand J Infect Dis 1975; 7: 127–34.

Sutter VL Finegold SM. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother 1976; 10: 736–52.

Sutter VL Finegold SM. In vitro studies with metronidazole against anaerobic bacteria. In: Finegold SM , ed. Metronidzole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 279–85.

Chow AW Bendnorz D Guze LB. Susceptibility of obligate anaerobes to metronidazole: an extended study of 1054 clinical isolates. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 286–92.

Watt B Jack EP. Susceptibility of anaerobic cocci to imidazole derivatives with special reference to metronidazole and sulnidazole. In: Siegenthaler W Luthy R , eds. Curcent chemotherapy. Proceedings of the 10th international congress of chemotherapy. Zurich, September 1977. Washington, DC: American Society of Microbiology, 1978; 2: 716.

Dubois J Pechere JC Turgeon P. Activity of ten antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother 1978; 4: 329–34.

Warner JF Prior RB. Clinical and in vitro studies of the bactericidal activity of metronidazole against anaerobic bacteria. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazode conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 359–67.

Whelan JPF Hale JH. Bactericidal activity of metronidazole against Bacteroides fragilis. J Clin Pathol 1973; 26: 393–5.

Busch DF Sutter VL Finegold SM. Activity of combinations of antimicrobial agents against Bacteroides fragilis. J Infect Dis 1976; 133: 321–6.

Salem AR Jackson DD McFadzean JA. An investigation of interactions between metronidazole (Flagyl) and other antibacterial agents. J Antimicrob Chemother 1975; 1: 387–9.

Ingham HR Eaton S Venables CW Bacteroides fragilis resistant to metronidazole after long term therapy. Lancet 1978; 1: 214–5.

Willis AT Jones PH Phillips KD Metronidazole resistance among Bacteroides fragilis. Lancet 1978; 1: 721.

Tally FP Snydman DR Shimell MJ Goldin HR. Mechanisms of antimicrobial resistance of Bacteroides fragilis. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 19–27.

Onderdonk AB Weinstein WM Sullivan NM Bartlett JG Gorbach SL. Experimental intra-abdominal abscesses in rats. II. Quantitative bacteriology of infected animals. Infect Immun 1974: 10: 1256–9.

Onderdonk AB Louie TJ Tally FP Bartlett JG. Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis. J Antimicrob Chemother 1979; 5: 201–10.

Chrystal EJT Koch RL McLafferty MA Goldman P. Relationship between metronidazole metabolism and bactericidal activity. Antimicrob Agents Chemother 1980; 18: 566–73.

Searle Pharmaceuticals, Inc. Flagyl I.V.® (metronidazole), a clinical and laboratory profile. Chicago, 1980.

Houghton GW Thorne PS Smith J The pharmacokinetics of intravenous metronidazole. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 35–40.

Eykyn SJ Phillips I. Metronidazole and anaerobic sepsis. Br Med J 1976; 2: 1418–21.

Winter ME. Basic clinical pharmacokinetics. San Francisco: Applied Therapeutics, Inc., 1980: 46–8.

Opperman J Azernoff D Hunt W Pharmacokinetics of intravenously administered ¹⁴C-metronidazole hydrochloride in man. Am Soc Microbiol 1978: S26.

Houghton GW Smith J Thorne PS The pharmacokinetics of oral and intravenous metronidazole in man. J Antimicrob Chemother 1979; 5: 621–3.

Houghton GW Thorne PS Smith J Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol 1978; 8: 337–41.

Gabriel R Page CM Weller IVD The pharmacokinetics of metronidazole in patients with chronic renal failure. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 49–54.

Cerat GA Cerat LL McHenry MC Metronidazole in renal failure. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 404–14.

Templeton R. Metabolism and pharmacokinetics of metronidazole: a review. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 28–49.

Bryan CS Huffman LJ Del Bene VE Intravenous metronidazole therapy for Bacteroides fragilis meningitis. South Med J 1979; 72: 494–7.

Warner JF Perkins RL Cordero L. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. Arch Intern Med 1979; 139: 167–9.

Schwartz DE Jeunet F. Comparative pharmacokinetic studies of ornidazole and metronidazole in man. Chemotherapy 1976; 22: 19–28.

Stanbaugh JE Feo LG Manthei RW. The isolation and identification of the urinary oxidative metabolites of metronidazole in man. J Pharmacol Exp Ther 1968; 161: 373–81.

Smith JA Skidmore AG Forward AD Clarke AM Sutherland E. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis. Ann Surg 1980; 192: 213–20.

Food and Drug Administration. Metronidazole, summary basis of approval. NDA 18-353. December 1980.

Rissing JP Moore WL Newman C Treatment of anaerobic infections with metronidazole. Curr Ther Res 1980; 27: 651–63.

Eykyn SJ Path MRC Phillips I. Intravenous metronidazole in the treatment of anaerobic sepsis. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 393–403.

Eykyn SJ Phillips I. Metronidazole in surgical infections. J Antimicrob Chemother 1978; 4 (suppl C): 75–81.

Platt LD Yonekura ML Ledger WJ. The role of anaerobic bacteria in postpartum endomyometritis. Am J Obstet Gynecol 1979; 135: 814–7.

Selkon JB Ingham HR Roxby CM. The bacteriology and chemotherapy of cerebral abscesses secondary to middle ear disease and dental sepsis. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 221–8.

Law BJ Marks M. Excellent outcome of Bacteroides meningitis in a newborn treated with metronidazole. Pediatrics 1980; 66: 463–5.

Hunt LW Agre K Oppermann J Nissen C. Intravenous and oral administration of metronidazole in anaerobic infection. In: Nelson JD Grossi C , eds. Current Chemotherapy and Infectious Disease. Proceedings of the 11th ICC and the 19th ICAAC. Washington, DC: American Society of Microbiology, 1980: 875–7.

Galgiani JN Busch DF Brass C Bacteroides fragilis endocarditis, bacteremia and other infections treated with oral or intravenous metronidazole. Am J Med 1978; 65: 284–9.

Seggie J. Fusobacterium endocarditis treated with metronidazole. Br Med J 1978; 1: 960–1.

Sanders CV Hanna BJ Lewis AC Scalcini M. The use of metronidazole in the treatment of anaerobic pleuropulmonary infections. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 83–9.

Eykyn SJ. Metronidazole in the treatment of extra-abdominal anaerobic infections. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 75–81.

Ellis CJ. How should we use metronidazole?. J Antimicrob Chemother 1980; 6: 305–7.

Greenall MJ Bakron A Pickford IR A double-blind trial of a single intravenous dose of metronidazole as prophylaxis against wound infection following appendicectomy. Br J Surg 1979; 66: 428–9.

Gottrup F. Prophylactic metronidazole in the prevention of infection after appendectomy. A double blind trial. Scand J Gastroenterol 1980; 15 (suppl 58): 114.

Chant ADB. A comparison of the prophylactic value of metronidazole and ampicillin in appendectomy. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 125–7.

Keighley MRB Arabi Y Alexander-Williams J Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet 1979; 1: 894–7.

Aeberhard P Berger J Casey P. A comparison of oral bowel preparation and intravenous chemotherapy given at the time of operation. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 173–7.

Dion YM Richards GK Prentis JJ Hinchey EJ. The influence of oral versus parenteral preoperative metronidazole on sepsis following colon surgery. Ann Surg 1980; 192: 221–6.

Eykyn SJ Jackson BT Lockhart-Mummery HE Phillips I. Prophylactic perioperative intravenous metronidazole in elective colorectal surgery. Lancet 1979; 2: 761–4.

Hughes TBJ Frampton J Begg HB Khan MS. The prophylactic effect of a short course of intravenous metronidazole during gynecological surgery. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 207–10.

Vaughan JE. Comparison of metronidazole and cephradine in the prevention of wound sepsis following Caesarean section. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 203–5.

Morgan IFK. Metronidazole treatment in pregnancy. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection, Geneva, April 1979. New York: Grune and Stratton, 1979: 245–7.

Roe FJC. A critical appraisal of the toxicology of metronidazole. In: Phillips I Collier J , eds. Metronidazole. Proceedings of the 2nd international symposium on anaerobic infection. Geneva, April 1979. New York: Grune and Stratton, 1979: 215–22.

Rosenkranz HS Speck WT. Studies on the significance of the mutagenicity of metronidazole for Salmonella typhimurium. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 119–25.

Roe FJC. Metronidazole: tumorigenicity studies in mice, rats and hamsters. In: Finegold SM , ed. Metronidazole. Proceedings of the international metronidazole conference. Montreal, May 1976. Princeton, NJ: Excerpta Medica, 1977: 132–7.

Goldman P. Metronidazole: proven benefits and potential risks. Johns Hopkins Med J 1980; 147: 1–9.

Koch RL Beaulieu BB Chrystal EJT Goldman P. A metronidazole metabolite in human urine and its risk. Science 1981; 211: 398–400.

Beard CM Noller KL O'Fallon WM Lack of evidence for cancer due to use of metronidazole. N Engl J Med 1979; 301: 519–21.

Friedman GD. Cancer after metronidazole (letter). N Engl J Med 1980; 302: 519.

Lefebure Y Hesseltine HC. The peripheral white blood cells and metronidazole. JAMA 1965; 194: 127–30.

Saginur R Hawley CR Bartlett JG. Colitis associated with metronidazole therapy. J Infect Dis 1980; 141: 772–4.

Frytak S Moertel CG Childs DS Phase II study of metronidazole therapy for advanced colorectal carcinoma. Cancer Treat Rep 1978; 62: 483–5.

O'Reilly RA. The stereoselective interaction of warfarin and metronidazole in man. N Engl J Med 1976; 295: 354–7.

Kazmier FJ. A significant interaction between metronidazole and warfarin. Mayo Clin Proc 1976; 51: 782–4.

Lehmann HE Ban TA. Chemical reduction of compulsion to drink with metronidazole: new treatment modality in therapeutic program of alcoholic. Curr Ther Res 1967; 9: 419–24.

Rothstein E Clancy DD. Toxicity of disulfiram combined with metronidazole. N Engl J Med 1969; 280: 1006.

Goodhue WW. Disulfiram-metronidazole toxicity. N Engl J Med 1969; 280: 1482.

Rissing JP Newman C Moore WL. Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole. Antimicrob Agents Chemother 1978; 14: 636–8.